About: http://webisa.webdatacommons.org/1056566

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	As you saw I think probably three, four weeks ago, there was a company who licensed a RAF inhibitor to Roche-Plexxikon for a polycystic kidney disease.
http://www.w3.org/ns/prov#wasQuotedFrom	seekingalpha.com